16 September 2026 note archive · Item
Medtrum TouchCare Nano CGM: review notes
These archived notes document the scope reviewed on 16 September, including source-access limits. They do not cover later changes or newly added records. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Medtrum TouchCare Nano CGM
Scope and findings: Added in the second discovery pass. A standalone or Medtrum-pump-integrated CGM with a rechargeable transmitter and up to14-day sensor wear. It reports every two minutes and offers optional calibration. Numerical claims are tied to the cited product specifications or named study, and editorial scores do not represent measured comparative performance.
Primary sources checked:
- Medtrum TouchCare Nano CGM specifications, MD1158/MD3658
- Medtrum UK purchase and NHS access information
Limits: Scope is the specific claims documented in the new record. Local stock, payer rules, every hardware variant and unreported head-to-head outcomes are not verified. Regulatory status, manufacturer marketing and clinical performance are distinct.